Company Filing History:
Years Active: 2008
Title: **Innovative Contributions of Søren Michael Madsen in Lactic Acid Bacteria**
Introduction
Søren Michael Madsen, located in Copenhagen, Denmark, is a notable inventor with a focus on biotechnological advancements. He holds a patent that highlights his contributions to the field of microbiology, specifically concerning the production of heterologous gene products through lactic acid bacteria.
Latest Patents
His singular patent, titled "Fermentation method for production of heterologous gene products in lactic acid bacteria," outlines a novel fed-batch or continuous process. The invention details the systematic steps for producing heterologous peptides, polypeptides, or proteins. This includes constructing a recombinant lactic acid bacterium that includes a nucleotide sequence coding for the desired products and regulatory sequences to control their expression. Furthermore, the patent emphasizes cultivating the recombinant bacteria under specific conditions to facilitate gene expression and harvesting the resultant products efficiently. The method proposes the use of a chemically defined or synthetic medium, which may be supplemented with yeast extract, optimizing the cultivation process.
Career Highlights
Søren Michael Madsen's career is distinguished by his innovative approach to biotechnology. As an inventor at Bioneer A/S, he has dedicated his expertise to enhancing the methodologies used in the production of essential gene products, significantly impacting the field.
Collaborations
Throughout his professional journey, Madsen has collaborated with talented colleagues, including Astrid Vrang and Lars Bredmose. Together, they work to advance the understanding and application of lactic acid bacteria in various biotechnological processes.
Conclusion
Søren Michael Madsen's contributions through his patent showcase his commitment to advancing biotechnological methods in the field of microbiology. His work not only enhances the understanding of lactic acid bacteria but also paves the way for future innovations in the production of vital gene products.